Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-39805-z, published online 19 August 2023

The Competing interests section in the original version of this Article was incomplete.

“G.A.-A., M.L., D.P., A.S., R.P., F.C.B., R.S., C.M., L.T., J.A.S., J.M.V., and G.B. were employees of Jecure Therapeutics when this work was performed. G.A.-A., M.L., D.P., A.S., R.P., R.S., C.M., L.T., A.E.F., J.A.S., J.M.V., and G.B. were shareholders of Jecure Therapeutics when this work was performed.”

now reads:

“G.A.-A., M.L., D.P., A.S., R.P., F.C.B., R.S., C.M., L.T., J.A.S., J.M.V., and G.B. were employees of Jecure Therapeutics when this work was performed. G.A.-A., M.L., D.P., A.S., R.P., R.S., C.M., L.T., A.E.F., J.A.S., J.M.V., and G.B. were shareholders of Jecure Therapeutics when this work was performed. A.E.F is an employee and stockholder of Novo Nordisk.”

The original Article has been corrected.